Hologic, Inc. HOLX announced an extension of its LOCalizer radiofrequency identification (“RFID”) tag’s CE Mark. Under the extended approval, the tag can now be implanted more than 30 days prior to ...

Regulators in Europe gave the greenlight to Hologic Inc.’s Localizer, an implanted wireless device that promises to provide doctors greater flexibility to minimize the impact of breast surgery, the ...

Deal further expands Hologic’s portfolio of world-class breast health solutions addressing the full continuum of care The transaction supports Hologic’s strategy to provide a comprehensive suite of ...

Hologic Inc has acquired Somatex Medical Technologies, a provider of biopsy site markers and localization technologies, for approximately $64 million. The company was previously owned by E-Med ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) will showcase several recent developments in next-generation AI solutions at the 109 th Scientific Assembly and Annual Meeting of the ...

The breast lesion localization devices market is showing consistent expansion, with an estimated compound annual growth rate of approximately 7% over the forecast period. This growth is fueled by the ...

Leader in Women’s Health Will Unveil Groundbreaking Innovations With a Focus on Imaging Solutions and Artificial Intelligence Experience the cutting-edge Envision™ Mammography Platform (Graphic: ...

Hologic, a Marlborough-based medical device manufacturer, is expanding its product catalog through the planned $310-million acquisition of Endomagnetics, a breast cancer surgery technology developer.

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced that it signed a definitive agreement to acquire Endomagnetics Ltd (Endomag®), a ...